Preoperative subconjunctival combined injection of bevacizumab and mitomycin C before the surgical excision of primary pterygium: clinical and histological results

References

• HillJCMaskeRPathogenesis of pterygiumEye (Lond)19893pt 22182262695353
   PubMed Web of Science ®Google Scholar
• CameronMEHistology of pterygium: an electron microscopic studyBr J Ophthalmol19836796046086882718
   PubMed Web of Science ®Google Scholar
• KunimotoDKanitkarKMakarMThe Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease4th edPhiladelphia, PALippincott Williams & Wilkins20045051
   Google Scholar
• MauroJFosterCSPterygia: pathogenesis and the role of subconjunctival bevacizumab in treatmentSemin Ophthalmol200924313013419437347
   PubMed Web of Science ®Google Scholar
• KriaLOhiraAAmemiyaTImmunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygiumActa Histochem19969821952018739304
   PubMed Web of Science ®Google Scholar
• LeeCGLinkHBalukPVascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lungNat Med200410101095110315378055
   PubMed Web of Science ®Google Scholar
• FolkmanJKlagsbrunMAngiogenic factorsScience198723547874424472432664
   PubMed Web of Science ®Google Scholar
• TsanouEIoachimEStefaniotouMImmunohistochemical study of angiogenesis and proliferative activity in epiretinal membranesInt J Clin Pract200559101157116116178982
   PubMed Web of Science ®Google Scholar
• TanDTCheeSPDearKBLimASEffect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excisionArch Ophthalmol199711510123512409338666
   PubMedGoogle Scholar
  ErratumArch Ophthalmol19981164552
   Google Scholar
• BusinMHallidayBLArffaRCMcDonaldMBKaufmanHEPrecarved lyophilized tissue for lamellar keratoplasty in recurrent pterygiumAm J Ophthalmol198610222222273526904
   PubMed Web of Science ®Google Scholar
• KumariRSharmaAAjayAKBhatMKMitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular modelsMol Cancer200988719845939
   PubMed Web of Science ®Google Scholar
• WangXYCrowstonJGWhiteAJZoellnerHHealeyPRInterferon-alpha and interferon-gamma modulate Fas-mediated apoptosis in mitomycin-C-resistant human Tenon’s fibroblastsClin Experiment Ophthalmol201442652953824224571
   PubMed Web of Science ®Google Scholar
• NassiriNFarahangizSRahnavardiMRahmaniLNassiriNCorneal endothelial cell injury induced by mitomycin-C in photorefractive keratectomy: nonrandomized controlled trialJ Cataract Refract Surg200834690290818498993
   PubMed Web of Science ®Google Scholar
• KatırcıogluYAAltiparmakUEngur GoktasSCakirBSingarEOrnekFComparison of two techniques for the treatment of recurrent pterygium: amniotic membrane vs conjunctival autograft combined with mitomycin CSemin Ophthalmol2015305–632132724506693
   PubMed Web of Science ®Google Scholar
• DonnenfeldEDPerryHDFromerSDoshiSSolomonRBiserSSubconjunctival mitomycin C as adjunctive therapy before pterygium excisionOphthalmology200311051012102612750105
   PubMed Web of Science ®Google Scholar
• HurwitzHFehrenbacherLNovotnyWBevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancerN Engl J Med2004350232335234215175435
   PubMed Web of Science ®Google Scholar
• RosenfeldPJMoshfeghiAAPuliafitoCAOptical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age related macular degenerationOphthalmic Surg Laser Imaging2005364331335
   PubMed Web of Science ®Google Scholar
• WuPCKuoHKTaiMHShinSJTopical bevacizumab eye drops for limbal-conjunctival neovascularization in impending recurrent pterygiumCornea200928110310419092418
   PubMed Web of Science ®Google Scholar
• BancroftJDGambleMTheory and Practice of Histological Techniques2nd edLondonChurchill Livingstone2002
   Google Scholar
• AspiotisMTsanouEGorezisSAngiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1Eye (Lond)20072181095110116823458
   PubMed Web of Science ®Google Scholar
• LiangQFXuLJinXYYouQSYangXHCuiTTEpidemiology of pterygium in aged rural population of Beijing, ChinaChin Med J (Engl)2010123131699170120819632
   PubMed Web of Science ®Google Scholar
• TomaszMMitomycin C: small, fast and deadly (but very selective)Chem Biol1995295755799383461
   PubMedGoogle Scholar
• HosseiniHNejabatMKhaliliMRBevacizumab (Avastin) as a potential novel adjunct in the management of pterygiaMed Hypotheses200769492592717367957
   PubMed Web of Science ®Google Scholar
• GhoneimEMAbd-El GhnyAAGab-AllahAAKamalMZPreoperative subconjunctival injection of mitomycin C versus intraoperative topical application as an adjunctive treatment for surgical removal of primary pterygiumMiddle East Afr J Ophthalmol2011181374121572732
   PubMedGoogle Scholar
• MarcovichALMoradYSandbankJAngiogenesis in pterygium: morphometric and immunohistochemical studyCurr Eye Res2002251172212518239
   PubMed Web of Science ®Google Scholar
• LeeDHChoHJKimJTChoiJSJooCKExpression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygiaCornea200120773874211588427
   PubMed Web of Science ®Google Scholar
• GebhardtMMentleinRSchaudigUDifferential expression of vascular endothelial growth factor implies limbal origin of pterygiaOphthalmology200511261023103015885787
   PubMed Web of Science ®Google Scholar
• TengCCPatelNNJacobsonLEffect of subconjunctival bevacizumab on primary pterygiumCornea200928446847019411971
   PubMed Web of Science ®Google Scholar
• ShenasiAMousaviFShoa-AhariSRahimi-ArdabiliBFouladiRFSubconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trialCornea201130111219122221955635
   PubMed Web of Science ®Google Scholar
• RazeghinejadMBanifatemiMSubconjunctival bevacizumab for primary pterygium excision; a randomized clinical trialJ Ophthalmic Vis Res201491223024982728
   PubMedGoogle Scholar
• MahaMAmalMMohamedMIntraoperative subconjunctival bevacizumab as an adjunctive treatment in primary pterygium: a preliminary reportOphthalmic Surg Lasers Imaging201243645946622882007
   PubMedGoogle Scholar
• MohammadRHamidHFarzinAPreliminary results of subconjunctival bevacizumab in primary pterygium excisionOphthalmic Res20104313413819887878
   PubMed Web of Science ®Google Scholar
• ChangYSChenWCTsengSHSzeCIWuCLSubconjunctival mitomycin C before pterygium excision an ultrastructural studyCornea200827447147518434852
   PubMed Web of Science ®Google Scholar
• PasqualettiGDanesiRDel TaccaMBocciGVascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapyPharmacogenomics200781496617187509
   PubMed Web of Science ®Google Scholar